SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Hippieslayer who wrote (18717)4/6/1998 8:58:00 PM
From: Henry Niman  Respond to of 32384
 
FUGAZI, It really doesn't matter if 68%, 33%, or 10% of people taking a weight reduction drug had heart valve problems. The number of course depends on the definition of "problems". However, even 10% is sufficiently high to keep the drug off the market. There was no "scare". The drug is NOT safe.